San Diego-primarily based Viking Therapeutics marked by itself as a significant competitor inside the weight loss drug marketplace in February just after revealing promising knowledge from the mid-phase trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection As wel